Skip to main content

Advertisement

Log in

Efficacy of Probiotics and Nutrients in Functional Gastrointestinal Disorders: A Preliminary Clinical Trial

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The purpose of this study was to evaluate the efficacy and safety of commonly used probiotics and nutrients available for functional gastrointestinal disorders (FGID). Five different combinations of probiotics and nutrients, or placebo, were taken daily over 12 weeks. In this randomized controlled clinical trial, men and women 21 to 72 years of age with FGID symptoms of indigestion, bloating, and abdominal discomfort were assigned to one of six groups, 12 patients per group. Gastrointestinal Quality of Life Index (GIQLI) and visual analogue scale (VAS) for GI symptoms, SF-36, lactulose and mannitol test (LMT), and urine indican levels were evaluated. GIQLI, VAS scores, and LMT did not change significantly (P > 0.05). There were clinically notable improvements in two of the combination formulations. While the nonsignificant improvements in GI symptoms could suggest that combination probiotics and nutrients may be beneficial in conditions such as FGID, no conclusive evidence was found in this pilot trial. Further investigations to explore the findings are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Drossman DA (1995) Diagnosing and treating patients with refractory functional gastrointestinal disorders. Ann Intern Med 123:688–697

    CAS  PubMed  Google Scholar 

  2. Hyams JS (1999) Functional gastrointestinal disorders. Curr Opin Pediatr 11:375–378

    Article  CAS  PubMed  Google Scholar 

  3. Pare P (1999) Systematic approach toward the clinical diagnosis of functional dyspepsia. Can J Gastroenterol 13:647–654

    CAS  PubMed  Google Scholar 

  4. Drossman DA (1999) The functional gastrointestinal disorders and the Rome II process. Gut 45(Suppl 2):1–5

    Google Scholar 

  5. Drossman DA, Li Z, Andruzzi E, et al. (1993) U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 38:1569–1580

    Article  CAS  PubMed  Google Scholar 

  6. Glise H, Wiklund I, Hallerback B (1998) Burden of illness in functional gastrointestinal disorder—the consequences for the individual and society. Eur J Surg Suppl:67–72

  7. Drossman DA (2000) The functional gastrointestinal disorders. 2nd ed. Degnon Associates, McLean, VA

    Google Scholar 

  8. Hollander D (1999) Intestinal permeability, leaky gut, and intestinal disorders. Curr Gastroenterol Rep 1:410–416

    CAS  PubMed  Google Scholar 

  9. Madara JL (1990) Warner-Lambert/Parke-Davis Award lecture. Pathobiology of the intestinal epithelial barrier. Am J Pathol 137:1273–1281

    CAS  PubMed  Google Scholar 

  10. Ballard ST, Hunter JH, Taylor AE (1995) Regulation of tight-junction permeability during nutrient absorption across the intestinal epithelium. Annu Rev Nutr 15:35–55

    Article  CAS  PubMed  Google Scholar 

  11. Bjarnason I (1994) Intestinal permeability. Gut 35:S18–S22

    CAS  PubMed  Google Scholar 

  12. Sanderson IR, Walker WA (1993) Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology 104:622–639

    CAS  PubMed  Google Scholar 

  13. Ahmed T, Fuchs GJ (1997) Gastrointestinal allergy to food: a review. J Diarrhoeal Dis Res 15:211–223

    CAS  PubMed  Google Scholar 

  14. Knutson TW, Bengtsson U, Dannaeus A, Ahlstedt S, Knutson L (1996) Effects of luminal antigen on intestinal albumin and hyaluronan permeability and ion transport in atopic patients. J Allergy Clin Immunol 97:1225–1232

    CAS  PubMed  Google Scholar 

  15. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF (2004) Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 145:612–616

    Article  PubMed  Google Scholar 

  16. Hijazi Z, Molla AM, Al-Habashi H, Muawad WM, Molla AM, Sharma PN (2004) Intestinal permeability is increased in bronchial asthma. Arch Dis Child 89:227–229

    Article  CAS  PubMed  Google Scholar 

  17. Johnston SD, Smye M, Watson RG, McMillan SA, Trimble ER, Love AH (2000) Lactulose-mannitol intestinal permeability test: a useful screening test for adult coeliac disease. Ann Clin Biochem 37(Pt 4):512–519

    Article  CAS  PubMed  Google Scholar 

  18. D'Inca R, Di Leo V, Corrao G, Martines D, D'Odorico A, Mestriner C, Venturi C, Longo G, Sturniolo GC (1999) Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol 94:2956–2960

    PubMed  Google Scholar 

  19. Shorter RG, Huizenga KA, Spencer RJ (1972) A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease. Am J Dig Dis 17:1024–1032

    Article  CAS  PubMed  Google Scholar 

  20. Uil JJ, van Elburg RM, van Overbeek FM, Mulder CJ, VanBerge-Henegouwen GP, Heymans HS (1997) Clinical implications of the sugar absorption test: intestinal permeability test to assess mucosal barrier function. Scand J Gastroenterol Suppl 223:70–78

    CAS  PubMed  Google Scholar 

  21. Di Leo V, D'Inca R, Diaz-Granado N, Fries W, Venturi C, D'Odorico A, Martines D, Sturniolo GC (2003) Lactulose/mannitol test has high efficacy for excluding organic causes of chronic diarrhea. Am J Gastroenterol 98:2245–2252

    Article  PubMed  Google Scholar 

  22. Curzon G, Walsh J (1966) Value of measuring urinary indicant excretion. Gut 7:711

    Google Scholar 

  23. Greenberger NJ, Saegh S, Ruppert RD (1968) Urine indican excretion in malabsorptive disorders. Gastroenterology 55:204–211

    CAS  PubMed  Google Scholar 

  24. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA (1999) Functional bowel disorders and functional abdominal pain. Gut 45(Suppl 2):II43–II47

    Article  PubMed  Google Scholar 

  25. Bovee-Oudenhoven I, Termont D, Dekker R, Van der Meer R (1996) Calcium in milk and fermentation by yoghurt bacteria increase the resistance of rats to Salmonella infection. Gut 38:59–65

    CAS  PubMed  Google Scholar 

  26. Hirabayashi M, Matsui T, Yano H (1998) Fermentation of soybean flour with Aspergillus usamii improves availabilities of zinc and iron in rats. J Nutr Sci Vitaminol (Tokyo) 44:877–886

    CAS  Google Scholar 

  27. Kollist-Siigur K, Nielsen T, Gron C, Hansen PE, Helweg C, Jonassen KE, Jorgensen O, Kirso U (2001) Sorption of polycyclic aromatic compounds to humic and fulvic acid HPLC column materials. J Environ Qual 30:526–537

    Article  CAS  PubMed  Google Scholar 

  28. Hertkorn N, Permin A, Perminova I, Kovalevskii D, Yudov M, Petrosyan V, Kettrup A (2002) Comparative analysis of partial structures of a peat humic and fulvic acid using one- and two-dimensional nuclear magnetic resonance spectroscopy. J Environ Qual 31:375–387

    Article  CAS  PubMed  Google Scholar 

  29. Kailasapathy K, Chin J (2000) Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 78:80–88

    Article  CAS  PubMed  Google Scholar 

  30. Tannock GW (2002) The bifidobacterial and Lactobacillus microflora of humans. Clin Rev Allergy Immunol 22:231–253

    Article  PubMed  Google Scholar 

  31. Periti P, Tonelli F (2001) Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii. J Chemother 13:473–493

    CAS  PubMed  Google Scholar 

  32. Sanders ME, Morelli L, Tompkins TA (2003) Sporeformers as human probiotics: Bacillus, Sporolactobacillus, and Brevibacillus. Comp Rev Food Sci Food Safety 2:101–110

    Article  Google Scholar 

  33. Sanders ME, Morelli L, Bush S (2001) “Lactobacillus sporogenes” is not a Lactobacillus probiotic. Am Soc Microbiol News 67:385–386

    Google Scholar 

  34. Nakamura LK, Blumenstock I, Claus D (1988) Taxonomic study of Bacillus coagulans Hammer 1915 with a proposal for Bacillus smithii sp. Int J Syst Evol Microbiol 38:63–73

    Article  CAS  Google Scholar 

  35. Hoa NT, Baccigalupi L, Huxham A, Smertenko A, Van PH, Ammendola S, Ricca E, Cutting AS (2000) Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl Environ Microbiol 66:5241–5247

    Article  CAS  PubMed  Google Scholar 

  36. Hosoi T, Ametani A, Kiuchi K, Kaminogawa S (2000) Improved growth and viability of lactobacilli in the presence of Bacillus subtilis (natto), catalase, or subtilisin. Can J Microbiol 46:892–897

    Article  CAS  PubMed  Google Scholar 

  37. Pinchuk IV, Bressollier P, Verneuil B, Fenet B, Sorokulova IB, Megraud F, Urdaci MC (2001) In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother 45:3156–3161

    Article  CAS  PubMed  Google Scholar 

  38. Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H (1995) Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 82:216–222

    CAS  PubMed  Google Scholar 

  39. Bergmann JF, Chassany O (1998) The role of quality of life in functional gastrointestinal disorders: regulatory issues. Eur J Surg Suppl:87–91

  40. Damiano A, Handley K, Adler E, Siddique R, Bhattacharyja A (2002) Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS). Dig Dis Sci 47:1530–1537

    Article  PubMed  Google Scholar 

  41. Floch MH, Hong-Curtiss J (2002) Probiotics and functional foods in gastrointestinal disorders. Curr Treat Options Gastroenterol 5:311–321

    PubMed  Google Scholar 

  42. Saarela M, Lahteenmaki L, Crittenden R, Salminen S, Mattila-Sandholm T (2002) Gut bacteria and health foods—the European perspective. Int J Food Microbiol 78:99–117

    Article  CAS  PubMed  Google Scholar 

  43. Young RJ, Huffman S (2003) Probiotic use in children. J Pediatr Health Care 17:277–283

    Article  PubMed  Google Scholar 

  44. Isolauri E (2001) Probiotics in human disease. Am J Clin Nutr 73:1142S–1146S

    CAS  PubMed  Google Scholar 

  45. Kirjavainen PV, Gibson GR (1999) Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann Med 31:288–292

    CAS  PubMed  Google Scholar 

  46. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357:1076–1079

    Article  CAS  PubMed  Google Scholar 

  47. Laiho K, Ouwehand A, Salminen S, Isolauri E (2002) Inventing probiotic functional foods for patients with allergic disease. Ann Allergy Asthma Immunol 89:75–82

    Article  CAS  PubMed  Google Scholar 

  48. Vanderhoof JA, Young RJ (2003) Role of probiotics in the management of patients with food allergy. Ann Allergy Asthma Immunol 90:99–103

    PubMed  Google Scholar 

  49. Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17:895–904

    Article  CAS  PubMed  Google Scholar 

  50. Madden JA, Hunter JO (2002) A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr 88(Suppl 1):S67–S72

    Article  CAS  PubMed  Google Scholar 

  51. Saggioro A (2004) Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 38:S104–S106

    Article  PubMed  Google Scholar 

  52. Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M, Kamm MA, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53:1617–1623

    Article  CAS  PubMed  Google Scholar 

  53. Alvarez-Olmos MI, Oberhelman RA (2001) Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 32:1567–1576

    Article  CAS  PubMed  Google Scholar 

  54. Plummer S, Weaver MA, Harris JC, Dee P, Hunter J (2004) Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol 7:59–62

    PubMed  Google Scholar 

  55. Teitelbaum JE, Walker WA (2002) Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Annu Rev Nutr 22:107–138

    Article  CAS  PubMed  Google Scholar 

  56. Brown AC, Valiere A (2004) Probiotics and medical nutrition therapy. Nutr Clin Care 7:56–68

    PubMed  Google Scholar 

  57. Fioramonti J, Theodorou V, Bueno L (2003) Probiotics: what are they? What are their effects on gut physiology? Best Pract Res Clin Gastroenterol 17:711–724

    Article  CAS  PubMed  Google Scholar 

  58. Miraglia del Giudice M, De Luca MG (2004) The role of probiotics in the clinical management of food allergy and atopic dermatitis. J Clin Gastroenterol 38:S84–S85

    Article  CAS  PubMed  Google Scholar 

  59. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R, Kozakova H, Rossmann P, Bartova J, Sokol D, Funda DP, Borovska D, Rehakova Z, Sinkora J, Hofman J, Drastich P, Kokesova A (2004) Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93:97–108

    Article  CAS  PubMed  Google Scholar 

  60. Duggan C, Gannon J, Walker WA (2002) Protective nutrients and functional foods for the gastrointestinal tract. Am J Clin Nutr 75:789–808

    CAS  PubMed  Google Scholar 

  61. Johnson IT (2001) New food components and gastrointestinal health. Proc Nutr Soc 60:481–488

    Article  CAS  PubMed  Google Scholar 

  62. Roberfroid M (2002) Functional food concept and its application to prebiotics. Dig Liver Dis 34(Suppl 2):S105–S110

    Article  PubMed  Google Scholar 

  63. Holzapfel WH, Haberer P, Geisen R, Bjorkroth J, Schillinger U (2001) Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr 73:365S–373S

    CAS  PubMed  Google Scholar 

  64. Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S (2001) Quality assurance criteria for probiotic bacteria. Am J Clin Nutr 73:393S–398S

    CAS  PubMed  Google Scholar 

  65. Cucchiara S, Falconieri P, Di Nardo G, Parcelii MA, Dito L, Grandinetti A (2002) New therapeutic approach in the management of intestinal disease: probiotics in intestinal disease in paediatric age. Dig Liver Dis 34(Suppl 2):S44–S47

    Article  PubMed  Google Scholar 

  66. Mombelli B, Gismondo MR (2000) The use of probiotics in medical practice. Int J Antimicrob Agents 16:531–536

    Article  CAS  PubMed  Google Scholar 

  67. von der Weid T, Ibnou-Zekri N, Pfeifer A (2002) Novel probiotics for the management of allergic inflammation. Dig Liver Dis 34(Suppl 2):S25–S28

    Article  PubMed  Google Scholar 

  68. Cross ML (2004) Immune-signalling by orally-delivered probiotic bacteria: effects on common mucosal immunoresponses and protection at distal mucosal sites. Int J Immunopathol Pharmacol 17:127–134

    CAS  PubMed  Google Scholar 

  69. Fedorak RN, Madsen KL (2004) Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 20:146–155

    Article  PubMed  Google Scholar 

  70. Timmerman HM, Koning CJ, Mulder L, Rombouts FM, Beynen AC (2004) Monostrain, multistrain and multispecies probiotics—a comparison of functionality and efficacy. Int J Food Microbiol 96:219–233

    Article  CAS  PubMed  Google Scholar 

  71. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM (2005) Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128:541–551

    Article  PubMed  Google Scholar 

  72. Vogelsang H, Schwarzenhofer M, Oberhuber G (1998) Changes in gastrointestinal permeability in celiac disease. Dig Dis 16:333–336

    Article  CAS  PubMed  Google Scholar 

  73. Wyatt J, Oberhuber G, Pongratz S, Puspok A, Moser G, Novacek G, Lochs H, Vogelsang H (1997) Increased gastric and intestinal permeability in patients with Crohn's disease. Am J Gastroenterol 92:1891–1896

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was conducted with funding support from Southwest College of Naturopathic Medicine & Health Sciences and grant sponsorship and products provided by Garden of Life. A special thank you goes to Dr. June Riedlinger and Dr. Arben Lasku for their critical appraisal of the manuscript and technical suggestions on the presentation and format of the data and results.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Linda S. Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

S. Kim, L., Hilli, L., Orlowski, J. et al. Efficacy of Probiotics and Nutrients in Functional Gastrointestinal Disorders: A Preliminary Clinical Trial. Dig Dis Sci 51, 2134–2144 (2006). https://doi.org/10.1007/s10620-006-9297-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9297-8

Keywords

Navigation